AI assistant
Xylem Inc. — Director's Dealing 2011
Nov 3, 2011
30109_dirs_2011-11-03_d8d2a979-5d08-45a0-ac55-c1d2a3bfa65c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2011-11-01
Reporting Person: Speetzen Michael T (Chief Financial Officer & SVP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-11-01 | Common Stock | A | 13285 | $0.00 | Acquired | 26008 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-01 | Employee Stock Option (Right to Buy) | $18.63 | A | 8772 | Acquired | 2016-03-05 | Common Stock (8772) | Direct |
| 2011-11-01 | Employee Stock Option (Right to Buy) | $30.03 | A | 12709 | Acquired | 2020-03-05 | Common Stock (12709) | Direct |
| 2011-11-01 | Employee Stock Option (Right to Buy) | $32.38 | A | 13608 | Acquired | 2021-03-03 | Common Stock (13608) | Direct |
Footnotes
F1: The total amount of securities beneficially owned following the reported transactions includes securities that were received in connection with the spin-off of Xylem Inc. from ITT Corporation in a transaction that was exempt from reporting under Rule 16a-9 under the Securities Exchange Act of 1934.
F2: 2,880 options are vested and exercisable and the remaining 5,892 options will vest on March 5, 2012.
F3: 4,237 options are vested and exercisable and the remainder will vest in two equal annual installments beginning on March 5, 2012.
F4: These options vest in three equal annual installments beginning on March 3, 2012.